Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07461103) titled 'Effect of Topical Insulin on Healing Rate of Pemphigus Lesions' on March 5.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: Alexandria University
Condition:
Pemphigus Vulgaris
Skin Erosion
Autoimmune Blistering Disease
Intervention:
Drug: insulin glargine
Drug: human insulin
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: June 22, 2024
Target Sample Size: 20
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/study...